Skip to main content
linkedin
CONTACT
Hit enter to search or ESC to close
Close Search
Menu
ABOUT LONGEVITY BIOTECH
About Us
Leadership Team
Board of Directors
Scientific Advisors
Careers
SCIENTIFIC APPROACH
Immune Rebalancing
Precision Neuroscience
Hybridtide™ Platform
Publications
PIPELINE
LBT-3627
Pipeline
CLINICAL TRIALS
INVESTORS
NEWSROOM
Newsroom
Longevity Biotech will attend the NSF Phase II SBIR Conference
By
kapp
No Comments
June 6-7, 2016 – Atlanta, GA
Longevity Biotech will attend the NSF Phase II SBIR Conference.
Close Menu
ABOUT LONGEVITY BIOTECH
About Us
Leadership Team
Board of Directors
Scientific Advisors
Careers
SCIENTIFIC APPROACH
Immune Rebalancing
Precision Neuroscience
Hybridtide™ Platform
Publications
PIPELINE
LBT-3627
Pipeline
CLINICAL TRIALS
INVESTORS
NEWSROOM
CONTACT
linkedin
